Addex Therapeutics (ADXN) Total Non-Current Liabilities (2022 - 2025)
Historic Total Non-Current Liabilities for Addex Therapeutics (ADXN) over the last 4 years, with Q3 2025 value amounting to $246699.7.
- Addex Therapeutics' Total Non-Current Liabilities fell 216.35% to $246699.7 in Q3 2025 from the same period last year, while for Sep 2025 it was $246699.7, marking a year-over-year decrease of 216.35%. This contributed to the annual value of $226134.3 for FY2024, which is 6632.69% down from last year.
- As of Q3 2025, Addex Therapeutics' Total Non-Current Liabilities stood at $246699.7, which was down 216.35% from $172538.7 recorded in Q2 2025.
- In the past 5 years, Addex Therapeutics' Total Non-Current Liabilities registered a high of $815919.0 during Q1 2022, and its lowest value of $39280.8 during Q1 2023.
- In the last 4 years, Addex Therapeutics' Total Non-Current Liabilities had a median value of $176277.6 in 2023 and averaged $247982.5.
- Data for Addex Therapeutics' Total Non-Current Liabilities shows a peak YoY increase of 65267.99% (in 2023) and a maximum YoY decrease of 9518.57% (in 2023) over the last 5 years.
- Quarter analysis of 4 years shows Addex Therapeutics' Total Non-Current Liabilities stood at $90337.0 in 2022, then soared by 652.68% to $679948.1 in 2023, then plummeted by 66.6% to $227093.2 in 2024, then increased by 8.63% to $246699.7 in 2025.
- Its last three reported values are $246699.7 in Q3 2025, $172538.7 for Q2 2025, and $146999.5 during Q1 2025.